Talicia s efficacy and safety profile evaluated in patients with H. pylori infection and diabetes mellitus, a large and challenging patient population.
- Oral opaganib s reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern.
- Oral opaganib s reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern.
/PRNewswire/ RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational.
/PRNewswire/ RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational.